Sagami Fumio | Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
スポンサーリンク
概要
- 同名の論文著者
- Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturersの論文著者
関連著者
-
Sagami Fumio
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sagami Fumio
第一三共安全性研究所
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Sagami Fumio
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
NAITO Shinsaku
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
Naito Shinsaku
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Kai Shuichi
東京都健康安全研究センター
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Onodera Hiroshi
東京都健康安全研究センター
-
小野寺 博志
Division Of Pathology National Institute Of Health Sciences
-
Onodera Hiroshi
Pharmaceuticals And Medical Devices Agency
-
Shinoda Kazutoshi
Pharmaceuticals and Medical Devices Agency
-
Amano Yukinori
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
SATO Gen
Drug Safety Research Laboratories
-
Sato Gen
Drug Safety And Disposition
-
Sato Gen
Drug Safety Research Laboratories Eisai Co. Ltd.
-
TANAKA Takeshi
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
YOSHIOKA Kaoru
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
TAKAHASHI Koichi
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
DODO Tetsushi
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
KURODA Satoko
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
UEYAMA Seiichi
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
ASANOMA Koji
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
MATSUZAWA Toshiaki
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
Onodera H
Pharmaceuticals And Medical Devices Agency
-
Asanoma Koji
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Dodo Tetsushi
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Kuroda Satoko
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Yoshioka Kaoru
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Ueyama Seiichi
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
HOSOKAWA Satoru
Drug Safety Research Lab., Eisai Co., Ltd.
-
Onodera Hiroshi
Dvision Of Pathology Biological Safety Research Center National Institute Of Health Sciences
-
SAGAMI Fumio
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Sagami Fumio
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Ohno Yasuo
第一三共安全性研究所
-
Inoue Tohru
Biological Safety Research Center, National Institute of Health Sciences
-
Ohno Yasuo
National Institute of Health Sciences
-
Kawai Mutsufumi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Okano K
Eisai Co. Ltd. Ibaraki Jpn
-
Okano Kazuo
Exploratory Division Eisai Tsukuba Research Laboratories Eisai Co. Ltd.
-
Okano Kazuo
Department Of Electrical System Engineering Polytechnic University
-
TSUKIDATE Kazuo
Drug Safety Research Laboratories, Eisai Co., Ltd
-
Mikami T
Safety Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Tagawa Masashi
Safety Research Department Teikoku Hormone Mfg. Co. Ltd.
-
SUGIHARA Yoshiki
Department of Drug Safety Research, Eisai Tsukuba Research Laboratories, Eisai Co., Ltd.
-
SHIONOYA Hiroshi
Department of Drug Safety Research, Eisai Kawashima Research Laboratories, Eisai Co., Ltd.
-
MIKAMI Takashi
Department of Drug Safety Research, Eisai Kawashima Research Laboratories, Eisai Co., Ltd.
-
KATAYAMA Kouichi
Exploratory Division, Eisai Tsukuba Research Laboratories, Eisai Co., Ltd.
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Tsukidate Kazuo
Global Drug Safety Eisai Co. Ltd.
-
Tsukidate Kazuo
Drug Safety Research Lab. Eisai Co. Ltd.
-
Ohno Yasuo
National Inst. Of Health Sci. Tokyo Jpn
-
Mikami T
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
KAI Shuichi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
早川 和宏
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
Kai Shuichi
ブリストルマイヤーズスクイブ
-
Sagami Fumio
Japan Pharmaceutical Manufacturers Association (jpma) Qt Prodact
-
Ohkura Takako
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Hisada Shigeru
Safety Research Department Developmental Research Center, ASKA Pharmaceutical Co., Ltd.
-
AOKI Toyohiko
Drug Safety Research Laboratories, Eisai Co., Ltd.
-
Sato Kunio
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
Aoki Toyohiko
Global Drug Safety Eisai Co. Ltd.
-
Hisada Shigeru
Safety Research Department Developmental Research Center Aska Pharmaceutical Co. Ltd.
-
Hisada Shigeru
Safety Research Department Aska Pharmaceutical Co. Ltd.
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Kawamura Nobuyuki
European Federation of Pharmaceutical Industries and Associations
-
Yamazaki Tsuneyoshi
Kyoritsu University of Pharmacy, Kyoritsu University of Pharmacy
-
Fueki Osamu
Pharmaceuticals and Medical Devices Agency
-
Inoue Tohru
Biological Safety Res. Center National Inst. Of Health Sciences
-
Kawahara Jun-ichi
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
TASHIRO Toshifumi
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Global Research and Development, P
-
田代 俊文
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
Tashiro Toshifumi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
細川 暁
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
Sato K
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
Inoue Akiharu
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Nemoto Shingo
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Kohira Terutomo
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Hosokawa S
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
Hosokawa Shunji
Environmental Health Science Laboratory Sumitomo Chemical Co. Ltd.
-
CHIMOTO Tadashi
Drug Safety and Disposition
-
HAYAKAWA Kazuhiro
Drug Safety & Disposition Research Laboratories, Eisai Co., Ltd.
-
KATSURAYAMA Tomiharu
Drug Safety & Disposition Research Laboratories, Eisai Co., Ltd.
-
SUMIGAMA Shuji
Drug Safety & Disposition Research Laboratories, Eisai Co., Lid.
-
Sumigama Shuji
Drug Safety & Disposition Research Laboratories Eisai Co. Lid.
-
Kawamura Naohisa
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
Yamazaki Tsuneyoshi
Kyoritsu University Of Pharmacy Kyoritsu University Of Pharmacy
-
Komori Masayuki
Division Of Analytical Biochemistry Faculty Of Pharmaceutical Sciences Hokkaido University
-
Kotosai Kounori
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
今井 敏夫
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
Komatsu Shinichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Kitajima Satoshi
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Satoh Kanako
東京都健康安全研究センター 環境保健部
-
Satoh Kanako
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Nakae Dai
東京都健康安全研究センター
-
Nakae Dai
Tokyo Metropolitan Institute Of Public Health
-
Shirao Kuniaki
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Sai Kimie
Divislon Of Toxicology National Institute Of Health Sciences
-
Sai-kato Kimie
Division Of Toxicology
-
Hakura Atsushi
Drug Safety Research Laboratories, Eisai Co., Ltd.
-
Sekita Kiyoshi
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Okuda Yasuyuki
Drug Safety Research Laboratories Eisai Co. Ltd.
-
INOUE Tadashi
Japan Pharmaceutical Manufactures Association
-
KITAJIMA Satoshi
Division of Cellular and Molecular Toxicology, BSRC, National Institute of Health Sciences
-
SANBUISSHO Atsushi
Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd.
-
Kimura Kazuya
Japan Pharmaceutical Manufacturers Assoc. Drug Evaluation Committee Non-clinical Evaluation Subcommi
-
Kumazawa Toshihiko
Safety Assessment Laboratory Sanwa Kagaku Kenkyusho Co. Ltd.
-
Kumazawa Toshihiko
Pharmaceutical Research Laboratories Sanwa Kagaku Kenkyusho Co. Ltd.
-
Yoshida Midori
National Institute of Health Sciences
-
Kudo Satoshi
Research Center, Kyorin Pharmaceutical Co., Ltd.
-
Ube Masayuki
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
Komatsu Shinichi
Pre-Clinical Development Department, Development & Medical Affairs Division, GlaxoSmithKline K.K.
-
HISADA SHIGERU
Japan Pharmaceutical Manufacturers Association
-
WAKATA AKIHIRO
Japan Pharmaceutical Manufacturers Association
-
Kudo Satoshi
Research Center Kyorin Pharmaceutical Co. Ltd.
-
Ube Masayuki
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Mutai Mamoru
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Okuda Yasuyuki
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
Yoshida Takemi
Showa Univ.
-
Yoshida Midori
Biological Safety Research Center National Institute Of Health Sciences
-
Yoshida M
National Agricultural Research Center For Hokkaido Region
-
Yoshida Midori
Division Of Pathology National Institute Of Health Sciences
-
Hisada Shigeru
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Heidel Shawn
Eli Lilly, Eli Lilly and Company
-
Kawakami Koji
Kyoto University
-
Kumagai Yuji
Showa University, School of Pharmaceutical Sciences
-
Inoue Tohru
National Institute of Health Sciences
-
Onodera Horoshi
Pharmaceuticals and Medical Devices Agency
-
Urano Tsutomu
Pharmaceuticals and Medical Devices Agency
-
Komiyama Noriyuki
Pharmaceuticals and Medical Devices Agency
-
Nishimura Chihiro
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
NAITO Shinsaku
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
FURUTA Shigeru
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
KITADA Mitsukazu
Chiba University Hospital
-
UNNO Takashi
Pharmaceutical Research and Manufactures of America
-
NAKAZAWA Takahiro
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
KAWAI Mutsufumi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
MAKI Eiji
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
Hakura Atsushi
Global Drug Safety Eisai Co. Ltd.
-
Hakura Atsushi
Drug Safety Research Laboratories Eisai Co. Ltb.
-
Okada Fumio
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
Maki E
Japan Pharmaceutical Manufacturers Assoc. Tokyo Jpn
-
Yoshida M
Genomic Sciences Center Riken
-
KAWAHARA Jun-ichi
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
INOUE Akiharu
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
MATSUMOTO Shinichi
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
KOHIRA Terutomo
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
NEMOTO Shingo
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
KOTOSAI Kounori
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
UNNO Takashi
Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacture
-
KOTOSAI Kounori
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
KAWAHARA Jun-ichi
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
INOUE Akiharu
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
OHKURA Takako
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
KOHIRA Terutomo
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
NAGAKI Yasuhiro
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
NEMOTO Shingo
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
MATSUMOTO Shinichi
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
NAITO Shinsaku
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
KAI Junko
Drug Safety Research Laboratories, Eisai Co., Ltd
-
Sakemi Kazue
Division Of Pharmacology And Biological Safety Research Center National Institute Of Health Sciences
-
Yoshida Midori
National Agricultural Research Center For Hokkaido Region
-
Yoshida Midori
Dept.pathol. Sasaki Inst.
-
Kawakami Koji
Dep. Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto Univ.
-
Kimura Kazuya
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Komatsu Shinichi
Pre-clinical Development Department Development & Medical Affairs Division Glaxosmithkline K.k.
-
Nishimura Chihiro
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Matsuda Yuzuru
President Kyowa Hakko Kogyo Co. Ltd.
-
Matsuda Yuzuru
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Inoue Tadashi
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Yoshida M
National Food Research Institute
-
Kitajima S
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Toritsuka Naoki
Drug Safety And Disposition Research Laboratories Eisai Co. Ltd.
-
Sanbuissho Atsushi
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.
-
Kai Junko
Drug Safety And Disposition Research Laboratories Eisai Co. Ltd.
-
Fueki Osamu
Pharmaceuticals And Medical Devices Agency Shin-kasumigaseki Building
-
Katoh Satoru
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Kumagai Yuji
Showa University School Of Pharmaceutical Sciences
-
Heidel Shawn
Eli Lilly Eli Lilly And Company
-
Imai T
Laboratory Of Pathology Aichi Cancer Center Research Institute
-
Yamasaki M
Biofrontier Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Furuta Shigeru
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Wakata Akihiro
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
KAKIKI Motoharu
Drug Metabolism and Pharmacokinetics Research, Eisai Co., Ltd.
-
Kakiki Motoharu
Drug Safety And Disposition Research Laboratories Eisai Co. Ltd.
-
SAWADA Shigeki
Drug Safety and Disposition Research Laboratories, Eisai Co., Ltd.
-
MOTOOKA Satoru
Drug Safety Research Laboratories, Eisai Co., Ltd.
-
Motooka Satoru
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Kitajima S
Division Of Cellular & Molecular Toxicology Biological Safety Research Center National Institute
-
KOBAYASHI Naoki
Discovery Technology Research Laboratories
-
SAGAMI Fumio
Medical Regulatory Affairs and Pharmacovigilance Department, Eisai Co., Ltd.
-
IMAI Toshio
Drug Safety & Disposition Research Laboratories, Eisai Co., Ltd.
-
Kitajima Satoshi
Division Of Cellular And Molecular Toxicology Biological Safety Research Center National Institute O
-
Sanbuissho Atsushi
Medicinal Safety Res. Laboratories Daiichi Sankyo Co. Ltd.
-
Yoshida M
Kyowa Hakko Kogyo Co. Ltd. Tokyo Jpn
-
Nagaki Yasuhiro
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
著作論文
- Collaborative work on evaluation of ovarian toxicity by repeated-dose and fertility studies in female rats
- Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance
- Points to consider on the non-clinical safety evaluation of anticancer drugs
- CURRENT OPINION : SAFETY EVALUATION OF DRUG METABOLITES IN DEVELOPMENT OF PHARMACEUTICALS
- "POINTS TO CONSIDER" REGARDING SAFETY ASSESSMENT OF BIOTECHNOLOGY-DERIVED PHARMACEUTICALS IN NON-CLINICAL STUDIES (ENGLISH TRANSLATION)
- Current status of pharmaceutical industries in Japan on pharmacogenomics and toxicogenomics in 2005(Toxicogenomics, Toxicoproteomics, Proceedings of the 32nd Annual Meeting)
- S3-6 Problems and Meanings of Genome-based Drug Discovery in Japanese Pharmaceutical Companies(SYMPOSIUM 3: BENEFITS OF PHARMACOGENOMICS/PHARMACOGENETICS IN PHARMACEUTICAL DEVELOPMENT)(Proceedings of the 31st Annual Meeting)
- P7-39 Current Analysis and Prospects of New Toxicological Biomarker : Biomarkers of Hepatotoxicity(GENERAL TOXICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P7-38 Current analysis and prospects of new toxicological biomarker : biomarkers of cardiotoxicity(GENERAL TOXICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P7-37 Current Analysis and Prospects of New Toxicological Biomarker : Biomarkers of Nephrotoxicity(GENERAL TOXICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- S13-1 Current analysis and prospects of new toxicological biomarkers : with central focus on heart, liver and kidney(SYMPOSIUM 13: CURRENT STATUS AND FUTURE ASPECTS OF NEW TOXICOLOGICALLY RESPONSIBLE BIOMARKERS)(Proceedings of the 31st Annual Meeting)
- STUDIES ON EXPERIMENTAL IODINE ALLERGY : 3. LOW MOLECULAR WEIGHT ELICITOGENIC ANTIGENS OF IODINE ALLERGY
- STUDIES ON EXPERIMENTAL IODINE ALLERGY : 2. IODINATED PROTEIN ANTIGENS AND THEIR GENERATION FROM INORGANIC AND ORGANIC IODINE-CONTAINING CHEMICALS
- STUDIES ON EXPERIMENTAL IODINE ALLERGY : 1. ANTIGEN RECOGNITION OF GUINEA PIG ANTI-IODINE ANTIBODY
- P-11 Application of hepatocytes cultured in a sandwich configuration to toxicity assessment.(Proceedings of the 27th Annual Meeting)
- Mechanism for benzothiazole derivative-induced hepatotoxicity in rats(SYMPOSIUM 1 : MECHANISMS OF HEPATOTOXIC EFFECTS)
- P-90 Collaborative Work to Evaluate Toxicity on Male Reproductive Organs with 2 Weeks Repeated Daily Dosing in Rats : Testicular Toxicity of E7010, A Sulfonamide Tubulin Polymerlzation Inhibitor(Proceedings of the 27th Annual Meeting)
- COLLABORATIVE WORK TO EVALUATE TOXICITY ON MALE REPRODUCTIVE ORGANS BY REPEATED DOSE STUDIES IN RATS : 17)TESTICULAR TOXICITY OF E7010, A SULFONAMIDE TUBULIN POLYMERIZATION INHIBITOR
- TOXICOLOGICAL RESPONSE OF RATS TO A NOVEL MONOAMINE OXIDASE TYPE-A INHIBITOR, (5R)-3-[2-((1S)-3-CYANO-1-HYDROX-YPROPYL)BENZOTHIAZOL-6-YL]-5-METHOXYMETHYL-2-OXAZOLIDI-NONE (E2011), ORALLY ADMINISTERED FOR 13 WEEKS
- "B-5 Modification of Drug Conjugation Pathway by Repeated Administration of Conjugating Enzyme Inhibitors in Rats.